A Randomized Placebo-controlled Single Center Pilot Study of the Safety and Efficacy of Tralokinumab in Subjects With Moderate to Severe Alopecia Areata

Trial Profile

A Randomized Placebo-controlled Single Center Pilot Study of the Safety and Efficacy of Tralokinumab in Subjects With Moderate to Severe Alopecia Areata

Recruiting
Phase of Trial: Phase II

Latest Information Update: 17 Apr 2017

At a glance

  • Drugs Tralokinumab (Primary)
  • Indications Alopecia areata
  • Focus Pharmacodynamics
  • Most Recent Events

    • 11 Apr 2017 Planned End Date changed from 1 Oct 2017 to 1 Apr 2018.
    • 11 Apr 2017 Planned primary completion date changed from 1 Oct 2017 to 1 Apr 2018.
    • 23 Feb 2016 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top